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Abbreviations 
 
AI = antibody index, B. burgdorferi  = Borrelia burgdorferi, CSF = cerebrospinal 
fluid, C. pneumoniae = Chlamydia pneumoniae, CP = chronic progressive, EAE = 
Experimental autoimmune encephalomyelitits, ECL = enhanced chemiluminescence,  
ELISA = Enzyme-linked-immunosorbent assay, IEF = Isoelectric focusing, Ig = 
immunoglobulin, MBP = Myelin Basic Protein, MOG = Myelin Oligodendrocyte 
Glycoprotein, MS =  Multiple Sclerosis, OD = Optical density, OIND = other 
inflammatory neurological diseases, OND = other neurological diseases, PCR = 
Polymerase chain reaction, RR = relapsing remitting,  
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Summary 
Multiple Sclerosis (MS) is one of the most frequent organic diseases of the nervous 
system, with a prevalence of 30-60 per 100,000 inhabitans. It is charcterized by an 
inflammatory destruction of the myelin sheaths in the white matter of the central 
nervous system, which may lead to severe disability and death. The underlying 
mechanism has not been clearly elucidated yet, but involves an attack of the body’s 
immune system against some of its own neural tissue antigens. One of the 
immunopathologic hallmarks of MS is the chronic intrathecal production of  
immunoglobulin (Ig). This contains IgG of very restricted variability, i.e. oligoclonal 
IgG, and in addition, recognizes a panel of different pathogens such as measles, 
rubella, and herpes zoster virus. While the antigen-specificity of the largest part of 
oligoclonal IgG in multiple sclerosis is unknown, the oligoclonal IgG arising during 
CNS infections are reactive against the specific pathogen. Recently, a link between 
Chlamydia (C.) pneumoniae and multiple sclerosis has been claimed. To test the 
possible role of C. pneumoniae in multiple sclerosis, we analyzed a) whether there is 
intrathecal IgG production against C. pneumoniae in multiple sclerosis and b) whether 
the oligoclonal IgG in the CSF of multiple sclerosis patients recognize C. 
pneumoniae. 
By studying paired serum/CSF samples from 120 subjects (definite multiple sclerosis: 
46; probable multiple sclerosis: 12; OIND: 35; OND: 27) by ELISA, we found that 
24% of all patients with definite multiple sclerosis, but only 5% of patients with other 
inflammatory or non-inflammatory diseases produced IgG specific for C. pneumoniae 
intrathecally (definite multiple sclerosis versus OIND: p = 0.027). The presence of 
intrathecal IgG to C. pneumoniae was independent of the duration of disease and 
relatively stable over time. The major CSF oligoclonal IgG bands from multiple 
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sclerosis-patients with an intrathecal Ig-production to C. pneumoniae did not react to 
C. pneumoniae by IEF-Western as seen by isolectric focusing and subsequent affinity-
mediated immunoblot (IEF-Western) towards purified elementary bodies and 
reticulate bodies of C. pneumoniae. By contrast, the IgG in the CSF of control 
patients with neuroborreliosis strongly reacted with their specific pathogen, Borrelia 
burgdorferi by IEF-Western. Concomitant analysis of the CSF of 23 patients with a 
nested PCR for C. pneumoniae was negative in all cases. Together, these findings 
strongly suggest that the immune response to C. pneumoniae is part of a polyspecific 
intrathecal Ig production, as is commonly observed with other pathogens. This argues 
against a specific role of C. pneumoniae in multiple sclerosis. 
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Zusammenfassung 
Die Multiple Sklerose (MS) ist eine der häufigsten organischen Erkrankungen des 
zentralen Nervensystems, mit einer Prävalenz von 30-60 pro 100.000 Einwohner. Sie 
zeichnet sich durch eine entzündliche Zerstörung der Myelinscheiden aus. Eine 
prominente immunpathologische Veränderung bei der MS ist die intrathekale 
Produktion von Immunglobulinen (Ig). Diese umfassen sogenannte oligoklonale 
Banden, die mit IEF darzustellen sind und deren Vorhandensein auch für die 
Diagnosefindung von Bedeutung ist. Darüberhinaus produzieren MS-Patienten 
intrathekal Ig gegen eine Vielzahl  verschiedener Pathogene, wie zum Beispiel 
Masern-, Röteln- und Varizella-Zoster-Viren. Während die Antigenspezifität der 
oligoklonalen IgG bei der MS weitestgehend unbekannt ist, reagieren die während 
einer Infektion des ZNS gebildeten oligoklonalen IgG mit dem spezifischen Pathogen. 
Kürzlich wurde ein Zusammenhang zwischen Chlamydia (C.) pneumoniae und der 
Multiplen Sklerose postuliert. Um diesen Erreger auf seine mögliche Rolle bei der 
Multiplen Sklerose hin zu prüfen, analysierten wir a) ob die Multiple Sklerose mit 
einer intrathekalen Produktion von IgG gegen C. pneumoniae verbunden ist und b) ob 
die oligoklonalen IgG im Liquor cerebrospinalis (CSF) von MS-Patienten C. 
pneumoniae erkennen. 
Indem wir gepaarte Serum-/CSF-Proben von 120 Patienten (gesicherte MS: 46, 
wahrscheinliche MS: 12, andere entzündliche neurologische Erkrankungen: 35, 
andere nichtentzündliche neurologische Erkrankungen: 27) mit dem Enzyme-linked 
Immunosorbent Assay (ELISA) untersuchten, fanden wir, dass 24% aller Patienten 
mit gesicherter MS aber nur 5% der Patienten mit anderen entzündlichen oder 
nichtentzündlichen Erkrankungen des ZNS intrathekal IgG spezifisch gegen C.  
pneumoniae produzierten (gesicherte MS versus andere entzündliche Neurologische 
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Erkrankungen: p = 0,027). Die Anwesenheit intrathekaler IgG gegen C. pneumoniae 
war unabhängig von der Krankheitsdauer und im zeitlichen Verlauf relativ stabil. Die 
hauptsächlichen oligoklonalen IgG-Banden im Liquor der Patienten mit Multipler 
Sklerose und intrathekaler Ig-Produktion gegen C. pneumoniae reagierten nicht mit 
C.p. Dies wurde in einem affinitätsvermittelten Immunoblot (IEF-western-blot) 
gesehen. Im Gegensatz dazu reagierten die IgG im CSF von Kontrollpatienten mit 
Neuroborreliose kräftig mit ihrem spezifischen Pathogen, Borrelia Burgdorferi, in der 
IEF-western-blot-Analyse. Zusammengenommen liefern diese Befunde starke 
Hinweise darauf, dass die Immunantwort gegen C. pneumoniae Teil einer 
polyspezifischen intrathekalen Ig-Produkton ist, wie man sie bei der MS gewöhnlich 
auch gegen andere Pathogene nachweist. Dies spricht gegen eine spezifische Rolle 
von C. pneumoniae bei der Pathogenese der MS. 
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Introduction 
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central 
nervous system (CNS) affecting 30-60 out of 100,000 inhabitants of Central Europe, 
the etiology of which remains unknown. Both infectious agents and pathological 
autoimmune reactions to CNS antigens have been implicated in the etiology of 
multiple sclerosis (Noseworthy et al., 2000). Recent neuropathological data have not 
only provided evidence for an important role of anti-myelin autoantibodies (Genain et 
al., 1999), but have also pointed to a considerable immunopathological heterogeneity 
of multiple sclerosis (Lucchinetti et al., 1998). Specifically, two patterns of multiple 
sclerosis plaques were identified that would be consistent with infectious or toxin-
induced demyelination (Lucchinetti et al., 2000). The pathogenetic heterogeneity of 
multiple sclerosis has obvious therapeutic consequences.  
An infectious etiology of multiple sclerosis has been suspected for more than a 
century, results from different areas of investigation pointing in this direction. 
Epidemiologic analysis of all cases of MS on the Faroe Islands from 1920 to 1977 
indicated a point source epidemic of MS, probably introduced by British troops or 
their baggage. Thus, MS on the Faroe Islands appeared to be a transmissible, most 
likely infectious, disease. Furthermore, studies of identical twins of which one has MS 
have shown that the disease develops in only 30% of second twins, indicating that 
more than a susceptible genotype determines disease (Spielman et al, 1982). Over the 
years a large number of different viruses have been linked to multiple sclerosis 
(Meinl, 1999), including measles virus, herpesviruses such as Epstein-Barr virus and 
human herpesvirus 6, human retroviruses (especially human T-cell-leukemia virus 
type 1), JC polyoma virus. To confuse matters further, anti-viral immune responses, 
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including intrathecal antibody production to such common pathogens as measles, 
rubella and herpes zoster viruses, are quite common in multiple sclerosis patients: 
they can be found in 60%, 60% and 50% of MS patients, respectively, and are present 
individually or in combination in more than 90% of MS patients (Reiber, 1995). 
These polyspecific anti-viral IgG do not correspond to the major oligoclonal IgG 
bands of the CSF and are considered as a bystander reaction (Measles-Rubella-Zoster 
(MRZ-) reaction) (Sindic et al., 1994; Luxton et al., 1995; Reiber et al., 1998). 
Furthermore, patients with multiple sclerosis have predominantly low affinity 
antibodies against these pathogens in the CSF, whilst patients with a primary viral 
infection have predominantly high affinity antibodies against the causative organism 
(Luxton et al., 1995). 
Very recently, C. pneumoniae has been linked to multiple sclerosis. Sriram 
and colleagues reported on a multiple sclerosis patient who failed to respond to 
immunosuppressive treatment, but had C. pneumoniae in the CSF and improved 
dramatically after antibiotic treatment (Sriram et al., 1998). In a larger cross-sectional 
study, the same group reported that C. pneumoniae could be cultured from 64 % of 
multiple sclerosis patients versus 11 % of controls and polymerase chain reaction 
(PCR) allowed the detection of C. pneumoniae genome in 97 % of multiple sclerosis 
patients versus 18 % of OND controls (Sriram et al., 1999). 
C. pneumoniae is an obligate intracellular bacterium that infects alveolar 
macrophages, monocytes and endothelial cells, including human brain 
microvasculature endothelial cells (MacIntyre et al,  2002) and infects only humans, 
generally causing pharyngitis, bronchitis and pneumonia. Over the last decade, 
substantial evidence of a causative role of C. pneumoniae in atherosclerosis has 
accumulated. In the field of neurology, C. pneumoniae has been detected in affected 
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brain tissue from patients with Alzheimer disease, the pathology of which is distinctly 
different from MS. Several case reports (summarized in Yucesan et al., 2001) of acute 
CNS manifestations such as Encephalitis, meningitis, Guillain-Barré-Syndrome 
associated with C. pneumoniae infection hint toward a possible neurotropism of the 
organism. Chlamydia bacteria have been linked to a chronic encephalopathy in cows, 
which is called sporadic bovine encephalomyelitis (Sriram et al., 1998; Harshfield, 
1970). Serology indicates that about half of the population in developed countries 
have had contact to C. pneumoniae (Hargreaves et al., 1994) and that seroconversion 
to C. pneumoniae interestingly usually occurs at 5 to 15 years of age (Thom DH et al., 
1991), the same time epidemiologic studies have indicated that MS is acquired, even 
though disease does not usually develop until after puberty. If C. pneumoniae 
were linked to the pathogenesis of certain subtypes of multiple sclerosis, this would 
have striking therapeutic consequences. Indeed, based on previous results (Sriram et 
al., 1999), clinical trials of antibiotic therapy are now underway (Treib et al., 2000). 
Several contradictory brief reports, mostly in the form of letters, have meanwhile 
appeared, shedding doubt on the Chlamydia hypothesis. The number of patients 
studied in these scattered reports was small, and data were mainly based on PCR 
analysis (Layh-Schmitt et al., 2000; Boman et al., 2000; Treib et al., 2000; Pucci et 
al., 2000; Hammerschlag et al., 2000; Li et al., 2000). However, the PCR detection of 
C. pneumoniae in the CSF is not standardized and the contradictory results might be 
explained by different PCR protocols, different strategies to extract DNA, different 
handling of the CSF, amount of CSF drawn, cell number in the CSF, and other 
variations.  
On the basis of experience with other infectious CNS diseases, it is evident 
that a negative PCR in the CSF does not exclude an infectious agent as a cause of 
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disease. For example, in herpes simplex encephalitis the PCR is positive only at the 
beginning of the disease. After about two weeks the PCR is usually negative, but the 
diagnosis can retrospectively be established by specific IgG production to herpes 
simplex virus and by specific reactivity of oligoclonal bands to this virus assessed by 
isoelectric focusing (IEF) with subsequent affinity mediated immunoblot (IEF- 
Western). This serological feature is very stable and reliable (Sauerbrei et al., 2000). 
Likewise, in neuroborreliosis the diagnostic sensitivity of the PCR from CSF was 
estimated to be just 17 %, and the diagnosis is routinely based on an intrathecal IgG 
production to Borrelia (B.)burgdorferi (Lebech et al., 2000). 
The aim of our present study was to test the Chlamydia hypothesis. We 
studied a total of 120 patients, using a combination of techniques, including 
conventional serology, IEF Western, and PCR. Immunoglobulins are stable outside 
the body and the experiments are not affected by the amount of CSF obtained and the 
speed of further processing. Most importantly, we examined the oligoclonal bands, 
which are present in 97% of MS patients (Zeman et al., 1995) and despite their not 
being restricted to MS, have been considered the “holy grail” in the search for the 
solution of the MS problem. Because, if C. pneumoniae infection was 
pathogenetically relevant, it would be expected that the major CSF oligoclonal bands 
are directed to this pathogen (Gilden, 1999).  
We found that an intrathecal IgG production to C. pneumoniae is indeed more 
common in multiple sclerosis patients than controls. However, in contrast to a 
previous report (Sriram et al., 1999), all our PCR results were negative. More 
importantly, we report the novel finding that in multiple sclerosis patients, the major 
CSF oligoclonal bands are not directed to C. pneumoniae as assessed by IEF-Western. 
This is in striking contrast to another chronic bacterial CNS infection, 
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neuroborreliosis, where IEF-Western analysis revealed a strong reactivity of B. 
burgdorferi-specific oligoclonal bands. Taken together, our results suggest that the 
intrathecal immune response to C. pneumoniae in multiple sclerosis is probably a 
bystander reaction, very similar to the well-known Measles-Rubella-Zoster (MRZ) 
reaction (Reiber et al., 1998). 
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Materials and Methods 
 
Patients 
Paired serum and CSF samples from a total of 120 patients were analyzed. Of these, 
12 patients were diagnosed as possible multiple sclerosis, 35 as RR-multiple sclerosis, 
and 10 as CP-multiple sclerosis (Poser et al., 1983). Thirty-five patients with diseases 
such as viral encephalitis, Guillain-Barré syndrome, meningitis, and chronic 
inflammatory demyelinating polyneuropathy were classified as other inflammatory 
neurologic diseases (OIND). Twenty-seven patients with diseases such as disc 
prolaps, headache, vertigo, and cerebral infarct were classified as other neurological 
diseases (OND) (Table 1). The serum and CSF samples were analysed in a blinded 
manner. For analysis of the antigen-specificity of the oligoclonal bands by IEF-
Western, four additional patients with definite neuroborreliosis were examined.  
 
Serology 
An ELISA specifically detecting IgG reactive with C. pneumoniae was obtained from 
Hain Diagnostics (Nehren, Germany, manufactured by Savyon Diagnostics, St 
Ashdod, Israel). Purified elementary bodies of strain TW-183 were used as antigen. In 
a recent comparative analysis this ELISA performed well in comparison with 
complement fixation and microimmunofluorescence (Persson, Boman, 2000). 
Seropositivity was assessed according to the instructions of the manufacturer using a 
1:100 dilution of the serum. To determine the presence of anti-C. pneumoniae IgG in 
the CSF, the spinal fluid was diluted 1:2. In analogy to evaluation of serum samples, 
CSF samples were scored positive for C. pneumoniae, if the measured optical density 
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was at least twice the optical density of the negative control, which was measured 
around an OD of 0.2.   
 
Determination of intrathecal IgG production 
 
To assess the presence of an intrathecal IgG production against C. pneumoniae, CSF 
was diluted 1:2 and the corresponding serum was diluted to the same concentration of 
IgG. The specific intrathecal IgG production antibody index (AI) was then calculated 
as AI = ODCSF : ODserum. In the case of an intrathecal IgG production, the corrected AI 
was calculated as AI x QIgG/Qlim. Qlim was calculated as described (Reiber, Lange, 
1991). An AI > 2 was considered to indicate a significant and reliable intrathecal IgG 
production against the pathogen studied. 
Immunoglobulins (Ig) in the CSF are either blood-derived or have been produced 
intrathecally. 
The proportion of blood-derived Ig is dependent upon blood-CSF-barrier function, 
measured as the CSF/serum concentration quotient of Albumin (Alb), QAlb. 
 
In patients that show no intrathecal Ig production, the relation between the 
CSF/Serum concentration quotients of Ig (QIg) and Albumin (QAlb) has been 
empirically determined. 
Based on these measurements and on the laws of diffusion (of molecules across the 
blood-CSF barrier), Reiber developped a formula by which one can calculate a 
maximum value for QIg , termed Qlim(Ig), in the absence of intrathecal Ig production. 
)(
)(
S
CSF
Alb Albc
AlbcQ = )(
)(
S
CSF
IgG IgGc
IgGcQ =
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A QIg exceeding Qlim(Ig ) indicates that part of Ig in the CSF originates from antibody 
forming cells within the CSF space. 
Qlim(Ig )  = the statistical upper limit of a blood-derived Ig fraction in CSF 
(comprising +/- 3 standard deviations or 99% of cases) 
 
The specific intrathecal immune response of a certain antibody species is expressed as 
Antibody Index (AI). 
AI = ratio between the specific antibody CSF/Serum concentration quotient, Qspec, and 
the total Ig CSF/Serum concentration quotient, QIg. 
 
 If there is intrathecal antibody synthesis, we refer to Qlim(Ig ) instead of QIg: 
 
Example of a patient(GCE) with an intrathecal immune response to Chlamydia 
pneumoniae: 
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Specific antibodies directed against Chlamydia pneumoniae were detected by ELISA: 
OD450nm (CSF) = 0.691 
OD450nm (Serum) = 0.460 
 
Since CSF and Serum were diluted to equivalent concentrations of IgG for ELISA, 
AI = Qspec = 1.53 
AI must be corrected for the intrathecal IgG synthesis: 
 
Since AI’ is greater than 2, this patients’ CSF contains intrathecally produced IgG 
against C.p. 
 
Culture and processing of C. pneumoniae and B. burgdorferi  
The C. Pneumoniae and B. Burgdorferi antigens being used in the IEF-Western blots 
have been prepared by M. Hartmann, Institute for Medical Microbiology, FSU Jena,  
and B. Wilske, Max-v-Pettenkofer-Institute, Munich, respectively, as described 
(Derfuss, Gürkov et al., 2001) 
 
[ ] 33623lim 1050.3107.1106)1089.4(93.0)( −−−− ⋅=⋅−⋅+⋅=IgGQ
53.1
460.0
691.0
==⇒ specQ
24.477.253.1'
lim
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Q
AIAI IgG
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IEF-Gels 
An isoelectric focusing (IEF) of Ig in the CSF can be performed in an agarose gel or a 
polyacrylamide gel. Agarose gels are more suitable for affinity mediated transfer, but 
polyacrylamide gels allow a better resolution of individual bands. Since the purpose 
of this part of the study was to perform a sensitive IEF Western analysis, agarose gels 
were chosen for these experiments. In addition, oligoclonal banding was revealed at 
high resolution in a subset of patients using polyacrylamide gels.  
To perform the IEF in agarose gels, unconcentrated CSF and serum were subjected to 
an IEF gel pH 3 – 10 according to the manufacturer’s guidelines (Titan Gel 
Electrophoresis Kit, Helena BioSciences, UK). All agarose IEF gels were run under 
the same conditions. Briefly, the IgG in CSF were diluted to 50 µg/ml in 0.9 % NaCl 
if they had a concentration higher than 50 µg/ml, and were used undiluted if they had 
a concentration lower than 50 µg/ml. The IgG in the serum was diluted to the 
respective CSF concentration. Five µl of the dilutions of CSF and serum were used 
for the IEF gel. After focusing, the gels were blotted on nitrocellulose paper for 30 
min with a weight of 1 kg. The blotted IgGs were detected with anti-human-IgG-HRP 
and ECL as a substrate. 
To determine the antigen-specificity of oligoclonal bands in the CSF, IEF and a 
subsequent affinity mediated immunoblot were performed. To this end the 
nitrocellulose paper was coated with 10 µg/ml antigen (5 ml / 12 cm2) (C. 
pneumoniae or B. burgdorferi) in 0.1 M carbonate buffer pH 9.5 overnight at 4°C 
before blotting. To block non-specific binding the nitrocellulose paper was 
subsequently incubated in 10% low fat milk powder for 1 h at room temperature. As a 
control, a part of the membrane was coated only with 10% milk powder for 1 h at 
room temperature. The IEF-Western protocol was adjusted such that no IgG blotted to 
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the membrane coated with milk powder. After blotting the IgG were detected with 
anti-human-IgG-peroxidase (supplied with the kit) or goat anti-human-IgG-biotin 
(Sigma) and streptavidin-peroxidase (Jackson). Anti-human-IgG-peroxidase was used 
to detect B. burgdorferi specific oligoclonal bands. For detection of C. pneumoniae 
specific oligoclonal bands the sensitivity had to be increased and the biotin-
streptavidin system was used. Using this biotin-streptavidin system the sensitivity 
could be increased by a factor of around 10. The blots were developed with the 
enhanced chemiluminescence (ECL) system. The signals were detected with X-ray 
films or the LAS 1000 (Fuji, Straubenhardt, Germany). For pI determination a 
calibration kit from Amersham Pharmacia was used. The marker was stained in the 
agarose gel with Coomassie. 
To validate the quality of the antigen and the coating procedure, a dot blot assay was 
performed. To this end, 2.5 µg of the antigen preparation were dotted on the 
membrane. After the spot had dried the membrane was blocked with 10 % milk 
powder for 1 hour at room temperature. Then the membrane was incubated with 
different dilutions of sera for 30 min at room temperature. Bound IgG were detected 
with goat-anti-human-peroxidase and the blot was developed with ECL. 
IEF was also performed in polyacrylamide gels (Amersham Pharmacia Biotech, 
Uppsala, Sweden) in a subset of patients to visualize the oligoclonal bands with this 
method. The gels were run according to manufacturer’s instructions. Briefly, 20 µl of 
serum and CSF diluted to an IgG concentration of 0.02 mg / ml were added on sample 
application pieces located 4 cm from the anode. The gel was run for 1.5 hours at 1500 
V and 10°C. Subsequently, proteins were silver stained as described (Wurster, 1983). 
 
 20 
 
Results  
 
Seroprevalence and intrathecal production of IgG specific for C. pneumoniae  
First, we screened all patients and controls for the presence or absence of a serum and 
CSF IgG response to C. pneumoniae. The proportion of seropositive patients was 
similar in the multiple sclerosis and control groups: About 50 % of all studied patients 
showed serological evidence of prior infection with C. pneumoniae (Table 1). 
 
 
Table 1. IgG response to C. pneumoniae in serum and CSF 
                       Group           
 
Probable 
MS 
Definite 
RR-MS 
Definite  
CP-MS OIND OND 
n 12 35 11 35 27 
Seropositive 
to C.p. 
5/12 
(42%) 
16/35 
(46 %) 
7/10 
(70 %) 
16/35 
(46 %) 
16/25 
(64%) 
Intrathecal 
IgG to C.p. 
1/12 
(8%) 
9/35 
(26%) 
2/11 
(18%) 
2/35 
(6%) 
1/26 
(4%) 
 
This table shows the number of patients studied and their classification. The number and percentage of 
patients who are seropositive for Cp and who displayed an intrathecal IgG production to Cp with an AI 
> 2 are shown. C.p. = Chlamydia pneumoniae. MS = multiple sclerosis 
 
 
 In this regard, there was no difference between multiple sclerosis patients and 
controls. Sixty patients were seropositive for C. pneumoniae. Out of these, 37 % had 
anti-C. pneumoniae IgG in the CSF. This ELISA is not sensitive enough to detect 
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transudation of IgG into the CSF of marginally seropositive patients. Conversely, 
among the identified 15 patients with an intrathecal IgG production to C. pneumoniae, 
11 scored positive for anti-C. pneumoniae IgG in the serum. 
In contrast, 26 % of patients with RR-multiple sclerosis and 20 % of patients 
with CP-multiple sclerosis (mean = 24 % for all patients with definite multiple 
sclerosis), but only 6 % of the OIND and 4 % of the OND patients showed an 
intrathecal IgG production to C. pneumoniae (Table 1). The specific AI in all patients 
with an intrathecal IgG response to C. pneumoniae was between 2.1 and 8 with a 
mean AI of 3.86. The difference between the proportion of patients with an intrathecal 
IgG response to C. pneumoniae in the definite multiple sclerosis group (11/46) and 
the OIND group (2/35) was statistically significant (Chi2 test: p = 0.027). The 
presence or absence of an intrathecal IgG production to C. pneumoniae did not 
correlate with disease duration: Eleven multiple sclerosis patients with intrathecal IgG 
production to C. pneumoniae had a mean disease duration of 10.4 years, whereas 29 
multiple sclerosis patients without intrathecal IgG production to C. pneumoniae had a 
mean disease duration of 10.0 years. Taken together, the results demonstrate that there 
is a difference between multiple sclerosis and controls in the intrathecal, but not in the 
serum IgG response to C. pneumoniae. 
 
 Stability of the antigen-specific intrathecal IgG production over time 
We assessed the temporal stability of anti-C. pneumoniae IgG by repeat CSF analysis 
in 9 patients. The time interval between the two CSF collections ranged from three 
weeks to 8 months. Five of these 9 patients showed an intrathecal IgG production to 
C. pneumoniae. In all 9 patients, the responder status (that is, presence or absence of 
an intrathecal IgG response) remained unchanged over the observation period. In 
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eight of the nine cases, the quantitative specific AI to C. pneumoniae was very stable 
over time. In one OIND patient, the corrected AI to C. pneumoniae dropped from 8.1 
to 3.4 after 5 months.  
In one multiple sclerosis-patient, we compared the time course of C. 
pneumoniae-specific IgG to the reactivity against several other infectious agents 
(Measles, Rubella, VZV, CMV and HSV). This patient, who had had clinically 
definite remitting-relapsing multiple sclerosis for twelve years, had elevated AIs to all 
these agents. This type of response has been described as the “Measles-Rubella-Zoster 
(MRZ)” reaction (Reiber et al., 1998). CSF was obtained at two time points, 6 months 
apart. After the first CSF sample revealed an intrathecal IgG response to C. 
pneumoniae, the patient was treated with doxycyclin (200 mg per day p.o.) for two 
weeks. As shown in Table 2, all AIs remained essentially unchanged. Together, the 
results show that the intrathecal immune response to C. pneumoniae, as well as to 
other infectious agents, is quite stable over time.  
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Table 2: Longitudinal stability of intrathecal IgG production against different 
pathogens 
 
 Date of lumbar puncture 
Corrected AI November 1999 July 2000 
C. pneumoniae 2.8 2.1 
B. burgdorferi negative negative 
Measles virus 9.1 9.9 
Rubella virus 22.2 18.6 
Varizella zoster virus 17.6 21.3 
Cytomegalovirus 1.9 2.5 
Herpes simplex virus 2.6 1.9 
 
CSF and serum of a patient with definite RR-multiple sclerosis was analysed for IgG against 
different viral antigens and C. pneumoniae at two different time points by ELISA.  The corrected AI 
that describe the intrathecally produced IgG against the different pathogens are shown.  
 
 
Antigen-specificity of oligoclonal bands 
Next, we tested the antigen-specificity of CSF oligoclonal bands by IEF-Western 
blotting, using C. pneumoniae, B. burgdorferi, and milk powder as antigens. Low fat 
milk powder is commonly used as a blocking reagent and served here to control the 
specificity and evaluate unspecific transfer. This analysis was done in all 15 samples 
with an intrathecal IgG production to C. pneumoniae (Table 1), in three samples with 
a high C. pneumoniae-specific OD in the ELISA in both serum and CSF and 
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additionally as a control in 8 samples without anti-C. pneumoniae IgG as assessed by 
ELISA.  
Eleven of the 15 patients with an intrathecal IgG production to C. pneumoniae 
had definite multiple sclerosis. In none of these 11 multiple sclerosis-patients were the 
oligoclonal bands in the CSF specific for C. pneumoniae. Ten of them did not show 
any specific response to C. pneumoniae in the IEF Western. A representative example 
is shown in Figure 1A. In one of these 11 patients, weak reactivity to C. pneumoniae 
was evident by IEF-Western (Figure 1B). 
 
 
Figure 1: Lack of reactivity of multiple sclerosis oligoclonal bands to C. 
pneumoniae 
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Figure 1. In A and left panel of B, CSF and serum of two multiple sclerosis-patients were analysed by 
IEF-Western. Both patients had an intrathecal IgG production to C. pneumoniae by ELISA. Patient 
GCe (A) (AI = 4.6) did not show any reactivity to C. pneumoniae in the IEF Western, while patient 
KoYu (B) (AI = 2.4) displayed a weak reactivity that seemed to be distinct from the major oligoclonal 
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bands. The membranes were coated with C. pneumoniae or milk powder as indicated. Immunoglobulin, 
which was affinity-mediated to the coated membranes, was detected with anti-human IgG-biotin, 
streptavidin-peroxidase, and ECL. The immunoglobulins blotted to the uncoated membranes were 
detected with the less sensitive system using anti-human IgG-peroxidase and ECL. IEF markers, which 
are indicated left in panel B, were stained in the gel with Coomassie. The right panel in B shows IEF of 
serum and CSF of patient KoYu in a silver stained polyacrylamide gel. The region between pH 9.3 
(indicated by the presence of cystatin C in the CSF) and pH 6.5 is shown. 
 
Two of the 4 control patients with an intrathecal IgG production to C. 
pneumoniae displayed reactivity to C. pneumoniae in the IEF Western. One 
representative example (patient HuM) of these two is shown (Figure 2B). This patient 
presented with hypoglycaemic coma, having a 32-years-history of type1-diabetes. 
PCR to detect C. pneumoniae in the CSF was not done in this patient. The other 
patient (NM) was diagnosed with limbic encephalitis of unknown origin and focal 
epileptic seizures. The CSF of this patient did not contain C. pneumoniae as assessed 
by PCR. It should be noted that the IEF-Western reactivity in these patient samples 
was only detected by the very sensitive method of applying streptavidin/biotin. This 
indicates that only a small minority of the IgG in the CSF was directed against C. 
pneumoniae.   
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Figure 2: Weak reactivity to C. pneumoniae in special cases 
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Figure 2. In A (left panel) the IEF Western of a patient PoVe (probable multiple sclerosis) with a high 
IgG response to C. pneumoniae in both serum and CSF, but without an intrathecal Ig production to C. 
pneumoniae (AI = 1.3) is shown. Both serum and CSF react to C. pneumoniae by IEF Western. In B 
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the IEF Western of patient HuM is shown. This patient, who suffered from a hypoglycemic coma and a 
long-standing diabetes mellitus, had an intrathecal IgG production against C. pneumoniae. In the IEF 
Western analysis IgG reactive to C. pneumoniae both in CSF and serum can be seen. The vertical line 
in A and B indicates that CSF and serum were run on different gels under the same focusing 
conditions. In A (left panel) and B membranes were coated with C. pneumoniae, milk powder as 
control, or were left uncoated. IgG was detected with anti-human IgG-biotin, streptavidin-peroxidase, 
and ECL on coated membranes and with the less sensitive anti-human IgG-peroxidase on uncoated 
membranes. The right panel in A shows IEF of serum and CSF of patient PoVe in a silver stained 
polyacrylamide gel. The region between pH 9.3 (indicated by the presence of cystatin C in the CSF) 
and pH 6.5 is shown. 
 
Three patients with high reactivity in serum and CSF to C. pneumoniae by 
ELISA, but without an intrathecal IgG production to C. pneumoniae (AI = 0.9, AI = 
1.0, and AI = 1.3) were also analysed by IEF Western. Two of them (PoVe with 
probable multiple sclerosis, LuAl with definite CP-multiple sclerosis) showed 
reactivity in both serum and CSF in the C. pneumoniae-directed IEF-Western. The 
third (ZiSa with RR-multiple sclerosis) did not react by IEF-Western. Of note, IEF-
Western analysis also detected bands in the serum of patients PoVe and LuAl. Again, 
specificity of this reactivity was confirmed by using milk proteins and B. burgdorferi 
as control antigens (data not shown). One representative example (PoVe) is shown in 
Figure 2A. The patient PoVe, who had probable multiple sclerosis, showed the 
strongest response to C. pneumoniae by IEF-Western. However, even in this patient, 
the very sensitive detection system was required (Figure 3). Importantly, since none 
of these two patients showed a quantitative intrathecal IgG response to C. 
pneumoniae, this bacterium is unlikely to be involved in their disease. The AI did not 
correlate with IEF-Western reactivity. This might be explained by the fact that the AI 
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reflects the ratio between CSF and serum reactivity and does not necessarily mirror 
the total amount of IgG in the CSF. 
 
 
Figure 3: Comparison of the IEF Western response to C. pneumoniae and B. 
burgdorferi using detection systems with different sensitivities 
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Figure 3. CSF and serum of patient NB 3 (neuroborreliosis) and CSF of patient PoVe (probable 
multiple sclerosis) were tested with different detection systems for their reactivity to B. burgdorferi and 
C. pneumoniae, respectively. Detection was performed either with the more sensitive anti-human IgG-
biotin and streptavidin-peroxidase (indicated as B+SA-PO) or with the less sensitive anti-human IgG-
peroxidase (indicated as PO). C. pneumoniae reactive oligoclonal bands in the CSF of patient PoVe can 
be observed only with the more sensitive detection system, whereas a strong reactivity to B. 
burgdorferi in the CSF of patient NB 3 can already be seen with the less sensitive detection system. As 
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indicated, membranes were coated with C. pneumoniae, B. burgdorferi, or milk powder as control. The 
applied IgG concentrations of samples from NB3 and PoVe were identical. 
 
For additional specificity control of the IEF-Western analysis, 8 patients (4 
with RR-multiple sclerosis, two with probable multiple sclerosis, one with CP-
multiple sclerosis, and one OIND patient) were studied who did not have reactivity to 
C. pneumoniae in the CSF measured by ELISA. When these 8 patients were analysed 
by IEF-Western for reactivity to C. pneumoniae, none of them showed any reactivity 
even when evaluated with the highly sensitive detection system.   
 
Further evaluation of the IEF Western Blot system and comparison with the 
immune response to B. burgdorferi 
To further validate our IEF-Western system, we analysed serum/CSF pairs from four 
patients with definite neuroborreliosis by IEF Western. These four control patients 
with neuroborreliosis showed a strong intrathecal IgG production to B. burgdorferi 
with a mean AI of 43.4.  
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Figure 4: IEF Western reactivity against B. burgdorferi of patients with 
neuroborreliosis 
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Figure 4. CSF of patient NB 1 with neuroborreliosis (panel A) was taken at the onset of disease and 
showed an intrathecal production of IgG against B. burgdorferi with an AI of 4. CSF of patient NB 2 
(panel B) was taken one year after onset of neuroborreliosis, the specific AI was 22. CSF and serum 
were separated by IEF and subsequently blotted to a nitrocellulose membrane coated with B. 
burgdorferi or milk powder. The IgG affinity mediated to the coated membranes and the IgG blotted to 
the uncoated membranes was detected with anti-human IgG-peroxide. 
 
All four patients showed – as expected – B. burgdorferi-specific oligoclonal 
IgG in the CSF (Figures 3 and 4). In addition, we analysed the reactivity of serum 
from the four patients to B. burgdorferi by IEF-Western. In three patients B. 
burgdorferi-specific reactivity was observed by IEF-Western in both serum and CSF. 
One representative patient is shown in Figure 4. In one patient the IEF-Western 
reactivity to B. burgdorferi was detected in CSF only (Figure 4B). In all 4 
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neuroborreliosis patients B.burgdorferi-specific oligoclonal IgG was readily detected 
with the less sensitive detection protocol using anti-human Ig-peroxidase, whereas 
detection of reactivity to C. pneumoniae by IEF-Western required the sensitive 
detection system (Figure 3). One of these neuroborreliosis patients was also cross-
examined with C. pneumoniae and did not react to this agent by IEF-Western (data 
not shown). The B. burgdorferi specific IgG response in CSF was strong and 
distributed over a broad range of pI (Figures 3 and 4). That makes a direct comparison 
of the oligoclonal IgG detected in the uncoated membrane with the B. burgdorferi-
specific oligoclonal IgG difficult. This observation is in accordance with an earlier 
study about B. burgdorferi-specific oligoclonal IgG in the CSF (Martin et al., 1988). 
As reported in the previous section, most of the patients who had a detectable 
intrathecal IgG production to C. pneumoniae in ELISA showed only weak or no 
reactivity of their oligoclonal bands to C. pneumoniae in IEF-Western, even with the 
sensitive technique. To exclude the possibilities of insufficient coating of the 
nitrocellulose membrane or alteration of the Chlamydia antigen during or after 
coating, we performed a series of additional experiments. First, CSF-IgG of patients 
PoVe and HuM reacted by IEF Western to C. pneumoniae, but not to B. burgdorferi 
(Figure 2 and data not shown). CSF of patient PoVe was run in parallel as a positive 
control in all IEF Western experiments searching for C. pneumoniae reactivity. 
Second, to further evaluate the efficiency of binding of C. pneumoniae, membranes 
were coated with C. pneumoniae and blocked with 10 % milk powder as for the IEF-
Western, and diluted serum samples were applied directly to the coated membranes 
without prior IEF-separation. Subsequently, the membranes were developed with the 
same detection system as used for the IEF-Western method. With this method, 
reactivity of the serum samples that were positive by ELISA could be detected at 
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dilutions down to 1:30,000. The results of these experiments show that the C. 
pneumoniae antigens bind efficiently to the nitrocellulose membrane and can be 
readily recognized by patients´ antibodies. 
 
 
 
Discussion 
Our analysis of 120 paired CSF and serum samples from multiple sclerosis patients 
and controls revealed the following: a) a positive serum IgG response to C. 
pneumoniae was observed in about 50 percent of multiple sclerosis patients and 
controls; b) in 20-25 % of multiple sclerosis-patients, but only 4-6 % of controls, there 
is clear evidence for intrathecal synthesis of antibodies directed against C. 
pneumoniae and c) IEF Western blotting demonstrated that in multiple sclerosis the 
major CSF-specific oligoclonal bands are not directed against C. pneumoniae.    
 
Seroprevalence and intrathecal IgG production 
The overall seroprevalence of C. pneumoniae in multiple sclerosis patients and 
control OIND and OND patients was similar. About 50 % of the patients and controls 
were seropositive for C. pneumoniae. This is within the range of expected 
seropositivity in the normal population. For example 43 % of basic trainees of the US 
airforce had preexisting Abs to C. pneumoniae (formerly called TWAR strain) 
(Hargreaves et al., 1994). This finding alone - that only about half of the multiple 
sclerosis patients show serological evidence of previous infection with C. pneumoniae 
- would argue against a role for C. pneumoniae in all multiple sclerosis-patients. 
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In contrast to the proportion of overall seropositivity, which was essentially 
identical between multiple sclerosis patients and controls, there was a clear difference 
in the proportion of patients with intrathecal antibody production to C. pneumoniae. 
This finding raises the question as to whether in this subgroup of multiple sclerosis-
patients, C. pneumoniae is directly linked to the pathogenesis or whether the 
intrathecal IgG production to C. pneumoniae is part of a bystander immune response 
known as the “MRZ reaction”(Luxton et al., 1995; Reiber et al., 1998).  
 
Specificity of oligoclonal IgG  in the CSF of multiple sclerosis patients 
Intrathecal IgG production and oligoclonal bands in the CSF represent typical 
laboratory features of MS and other inflammatory and infectious diseases of the CNS. 
The antigen-specificity of the oligoclonal IgG in MS is largely unknown. In the case 
of infectious CNS disease, at least part of the intrathecally produced oligoclonal IgG 
is directed to the specific pathogen. This has been reported for different virus 
infections of the CNS (Dörries, ter Meulen, 1984), B. burgdorferi and 
neuroborreliosis (Martin et al., 1988), and other infections of the CNS (reviewed by 
Gilden, 1999). Furthermore, the oligoclonal IgG in the CSF are stable over time in 
multiple sclerosis patients, suggesting that they are caused by a specific and chronic 
activation of B cells (Walsh, Tourtellotte, 1986), presumably by an antigen-driven 
response (Smith-Jensen et al., 2000). Therefore we tested whether the oligoclonal IgG 
present in multiple sclerosis CSF were specific for C. pneumoniae. For comparison, 
we analysed paired CSF/serum samples from patients with neuroborreliosis and 
determined the reactivity of their oligoclonal bands to the specific pathogen of this 
disease, B. burgdorferi. 
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The IEF-Western experiments revealed that the major oligoclonal IgG bands 
in the CSF of multiple sclerosis-patients did not react with C. pneumoniae. In 
contrast, all four analysed control patients with neuroborreliosis showed a strong 
intrathecal IgG-production against B. burgdorferi and strong reactivity of oligoclonal 
bands to this bacterium detectable by IEF-Western.  
What might be the reason for the strong reactivity of CSF oligoclonal IgG of 
neuroborreliosis patients to B. burgdorferi on the one hand and lack of reactivity of 
the major oligoclonal IgG of multiple sclerosis-patients to C. pneumoniae on the 
other? The IgG response to a specific pathogen involves a high percentage of the CSF 
Ig. About 20 % of the CSF IgG has been estimated to recognize measles virus in the 
case of subacute sclerosing panencephalitis (Conrad et al., 1994). In contrast, the 
concentration of those IgG that belong to the polyspecific immune response such as 
IgG directed to measles, rubella, and zoster virus represent together only about 2 % of 
the IgG in the CSF (Reiber et al., 1998). In addition, the intrathecal polyspecific IgG 
in multiple sclerosis is usually of low affinity in contrast to the IgG directed against a 
specific pathogen (Luxton et al., 1995). Both the low affinity and lower concentration 
of the anti-C. pneumoniae IgG in multiple sclerosis as compared to the anti-Borrelia 
IgG in neuroborreliosis might account for the weak or absent reactivity to C. 
pneumoniae in the affinity mediated IEF Western. 
Our finding that the major oligoclonal IgG in the CSF of multiple sclerosis-
patients are not directed against C. pneumoniae argues that the intrathecal IgG 
production against C. pneumoniae in a subgroup of multiple sclerosis is part of a 
polyspecific activation of B cells in the CSF. Longitudinal analysis revealed that the 
intrathecal IgG production to measles, rubella, and herpes zoster viruses, and at a 
lower level also to cytomegalovirus, herpes simplex virus, and C. pneumoniae, is 
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quite stable over time. Furthermore, the polyspecific IgG response to measles, rubella 
and zoster occurs rather independently of disease duration and is usually present at the 
onset of disease (Reiber et al., 1998). 
Two patients (one with probable multiple sclerosis (PoVe) and one with 
definite CP-multiple sclerosis (LuAl)) showed a few oligoclonal bands specific to C. 
pneumoniae in both serum and CSF. However, a highly sensitive detection system 
was required to demonstrate this reaction. The ELISA results indicate that these two 
patients had a rather high concentration of IgG against C. pneumoniae in both serum 
and CSF. Importantly, they did not show a specific intrathecal IgG production to C. 
pneumoniae (AI<2). The finding that these two patients showed C. pneumoniae-
specific oligoclonal bands in the CSF and serum by IEF-Western validates the IEF-
Western analysis. However, since these two patients did not display an intrathecal IgG 
production to C. pneumoniae, there is no evidence that this agent is causally related to 
their disease.  
 
Weak reactivity in IEF Western in special cases 
 One patient without evidence of an inflammatory CNS disease showed an 
intrathecal IgG production to C. pneumoniae and C. pneumoniae-specific oligoclonal 
bands in the IEF-Western analysis detected in both serum and spinal fluid. This might 
seem surprising, but it has been reported that an intrathecal IgG synthesis develops in 
5-10 % of patients with non-inflammatory neurological diseases (Tourtellotte, 
Tumani, 1997). An intrathecal IgG synthesis in patients presenting with non-
inflammatory neurological diseases is frequently regarded as an immune scar, since 
an intrathecal IgG synthesis persists for many years after overcoming of an  
encephalitis or meningitis.  
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Another patient, who had limbic encephalitis of unidentified origin, showed an 
intrathecal IgG production to C. pneumoniae and C. pneumoniae-specific oligoclonal 
bands exclusively in the CSF, but not in the serum. The CSF of this patient did not 
contain C. pneumoniae detectable by PCR. It should be noted that the reactivity to C. 
pneumoniae by IEF-Western was much weaker than the reactivity of the 
neuroborreliosis patients to B. burgdorferi and required a highly sensitive detection 
method. It remains to be established whether in this single case of encephalitis of 
unknown origin C. pneumoniae plays a pathogenic role. This patient recovered 
without a specific therapy.  
 
Animal models and the Chlamydia hypothesis 
The reports on the presence of C. pneumoniae in MS  patients that incited us 
to examine the matter have also led to increased efforts to show a role for C. 
pneumoniae in CNS autoimmunity in experimental allergic encephalomyelitis (EAE), 
the animal model for multiple sclerosis. One study (Du et al., 2002) could show that 
EAE in mice induced by immunization with myelin antigens  was worsened by 
concomitant infection of the animals with C. pneumoniae. The bacteria were also 
shown to be present in the CNS by Immunohistochemistry and PCR, but only in the 
tissue of animals suffering from EAE. Proliferation and IFN-γ production of 
autoreactive T cells was enhanced in diseased animals, but there was no evidence of 
cross-reactivity or molecular mimicry between the autoantigens and C. pneumoniae. 
Another group (Lenz et al., 2001) used a C. pneumoniae-derived peptide, which 
shows homology to myelin basic protein, to induce EAE in rats, whereas 
immunization with a sonicated C. pneumoniae preparation produced mild EAE in one 
out of five rats only. An intriguing study (MacIntyre et al., 2002) examined the effects 
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of C. pneumoniae infection of human brain microvascular endothelial cells on 
expression of proteins involved with blood brain barrier permeability and found that a 
downregulation of occludin by 60% at 36-48h post infection could allow for transient 
fluctuations in the permeability of the blood brain barrier. 
 
PCR results and comparison of the data with other  reports 
Different approaches including the culture of C. pneumoniae and PCR 
analysis of the CSF and autoptic brain have been undertaken to analyse a potential 
role for C. pneumoniae in the pathogenesis of multiple sclerosis. The detection of C. 
pneumoniae by culture is difficult and not very sensitive, because the viability of the 
organism decreases rapidly outside the host cell (Maass, Dalhoff, 1995). Since C. 
pneumoniae could not be detected by PCR in 23/23 of our CSF samples (Ten patients 
with definite RR-multiple sclerosis, 3 patients with definite CP-multiple sclerosis, 5 
patients with OIND and another 5 with OND) and since the PCR is more sensitive 
than culture, we did not attempt to culture C. pneumoniae (Derfuss, Gürkov et al., 
2001). 
Others looked at the presence of C. pneumoniae in multiple sclerosis patients’ 
brains. C. pneumoniae was not detected by PCR in any of the analysed patient and 
control specimens (Morre et al., 2000; Hammerschlag et al., 2000). These findings 
are consistent with the conclusion drawn from our different experimental approach. 
Different groups have looked for C. pneumoniae in CSF by PCR with highly 
ambiguous results. While the first report described positivity in 97 % of the CSF of 
multiple sclerosis patients (Sriram et al., 1999), two other studies were completely 
negative (Boman et al., 2000; Pucci et al., 2000). Another study detected C. 
pneumoniae by PCR in the CSF in 5/10 patients and then in a second series in 2/20 
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patients by PCR (Layh-Schmitt et al., 2000). Yet another study detected C. 
pneumoniae by PCR in 2/8 multiple sclerosis patients and found intrathecal IgG 
production in 8/22 multiple sclerosis patients (36%) (no data about control patients 
were reported) and initiated a placebo-controlled multicenter study to evaluate the 
efficiency of an antibiotic treatment with Roxithromycin (Treib et al., 2000). In 
contrast, however, another group detected C. pneumoniae in a high percentage of the 
CSF of both multiple sclerosis-patients and controls (Li et al., 2000). We did not find 
reproducible evidence for the presence of C. pneumoniae genome in any of the 
studied 23 CSF samples. The diverging results of previous PCR studies may depend 
on cell number, CSF amount, handling of the probe, and the specific PCR protocol. 
Still, one must consider that a negative PCR does by no means exclude an 
involvement of C. pneumoniae, since it has been established that in another chronic 
CNS disease, neuroborreliosis, in only about 17 % of the patients can B. burgdorferi 
be detected by PCR (Lebech et al., 2000).  
For these reasons we focused our study not on PCR or culture, but rather on 
the IgG response in the CSF and in serum. IgG is stable outside the body and the 
results are not affected by the amount of CSF obtained or the speed of further 
processing. Most importantly, it has been well established that oligoclonal bands 
specific for the respective pathogen arise in all kinds of infectious CNS diseases 
(Gilden, 1999). More recently, another group has studied CSF samples from 25 
adolescents with MS by ELISA and found intrathecal IgG production against C. 
pneumoniae in seven patients (28%). Furthermore, the authors calculated the 
proportion of anti-C. pneumoniae antibodies within the intrathecally produced total 
IgG to range from 0.01 to 0.8% only and thereby underpin our observations (Rostasy 
et al., 2003).  
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 Taken together, our study shows that a subgroup of about 25 % of multiple 
sclerosis-patients produces intrathecal IgG against C. pneumoniae. Importantly, even 
in this fraction of multiple sclerosis patients the major oligoclonal IgG in the CSF do 
not recognize C. pneumoniae. This strongly argues against a pathogenic role of this 
agent in multiple sclerosis. 
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